Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)
Clinical trial NCT04873869 · TERMINATED
Trial details
- NCT number
- NCT04873869
- Sponsor
- Neurocrine Biosciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-31
- Primary completion
- 2023-03-17
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.